FGFR1 and chronic kidney disease: When the non-CKD and CKD groups were compared in the Fgfr1–4flox/flox(non-cKO) genotype group, no marked difference was observed in the expression of any FGFR or αKlotho using the same immunohistochemistry conditions, although immunohistochemistry is not strictly a quantitative method.